Comparative and quantitative investigation of cell labeling of a 12-nm DMSA-coated Fe3O4 magnetic nanoparticle with multiple mammalian cell lines

Journal of Materials Research

Volumn 26, Issue 6, 2011, Pages 822-831

  Liu, Yingxun ^a   Wang, Jinke ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Magnetic; Nanoscale; Particulate

Indexed keywords

BIOCOMPATABILITY; CELL LABELING; CELL TYPES; CELL VIABILITY; COLORIMETRIC ASSAYS; DIMERCAPTOSUCCINIC ACIDS; HUMAN LIVER CELLS; IN-VIVO; IRON LOADING; IRON NANOPARTICLES; LABELING EFFECTS; MAGNETIC; MAGNETIC NANOPARTICLES; MAMMALIAN CELL LINES; MAMMALIAN CELLS; NANOSCALE; PARTICULATE; PRUSSIAN BLUE; QUANTITATIVE INVESTIGATION; TREATMENT TIME;

CELL CULTURE; CELLS; IRON; LOADING; MAMMALS; NANOPARTICLES;

NANOMAGNETICS;

EID: 80054947538     PISSN: 08842914     EISSN: 20445326     Source Type: Journal    
DOI: 10.1557/jmr.2010.60     Document Type: Article

References (42)

1. S. Y. Shaw, E. C. Westly, M. J. Pittet, A. Subramanian, S. L. Schreiber, and R. Weissleder: Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. USA 105, 7387 (2008).
2. M. M. Miller, G. A. Prinz, S. F. Cheng, and S. Bounnak: Detection of a micron-sized magnetic sphere using a ring-shaped anisotropic magnetoresistance-based sensor: A model for a magnetoresistancebased biosensor. Appl. Phys. Lett. 81, 2211 (2002).
3. T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky, and V. Labhasetwar: Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2, 194 (2005).
4. I. Chourpa, L. Douziech-Eyrolles, L. Ngaboni-Okassa, J. F. Fouquenet, S. Cohen-Jonathan, M. Souce, H. Marchais, and P. Dubois: Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst (Lond.) 130, 1395 (2005).
5. L. X. Tiefenauer: Magnetic nanoparticles as contrast agents for medical diagnosis in nanotechnology, in Biology and Medicine: Methods, Devices, and Applications, edited by T. Vo-Dinh (CRC Press, Taylor and Francis, Boca Raton, FL, 2007), pp. 1-20.
6. G. Morana, E. Salviato, and A. Guarise: Contrast agents for hepatic MRI. Cancer Imaging 7(Special issue A), S24 (2007).
7. M. M. J. Modo and J. W. M. Bulteì: Molecular and Cellular MR Imaging (CRC Press, Boca Raton, FL, 2007).
8. C. Corot, P. Robert, J. M. Idee, and M. Port: Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Delivery Rev. 58, 1471 (2006).
9. A. Ito, M. Shinkai, H. Honda, and T. Kobayashi: Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 8, 649 (2001).
10. R. Hergt and S. Dutz: Magnetic particle hyperthermia-biophysical limitations of a visionary tumour therapy. J. Magn. Magn. Mater. 311, 187 (2007).
11. H. Y. Nam, S. M. Kwon, H. Chung, S. Y. Lee, S. H. Kwon, H. Jeon, Y. Kim, J. H. Park, J. Kim, S. Her, Y. K. Oh, I. C. Kwon, K. Kim, and S. Y. Jeong: Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Controlled Release 135, 259 (2009).
12. B. D. Chithrani, A. A. Ghazani, and W. C. Chan: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662 (2006).
13. Z. P. Chen, Y. Zhang, S. Zhang, J. G. Xia, J. W. Liu, K. Xu, and N. Gu: Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanoparticles via surface doubleexchange with DMSA. Colloids Surf., A: 316, 210 (2008).
14. R. Pieters, D. R. Huismans, A. Leyva, and A. J. P. Veerman: Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. Br. J. Cancer 59, 217 (1989).
15. U. O. Häfeli, J. S. Riffle, L. Harris-Shekhawat, A. Carmichael-Baranauskas, F. Mark, J. P. Dailey, and D. Bardenstein: Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 6, 1417 (2009).
16. C. Wilhelm, C. Billotey, J. Roger, J. N. Pons, J. C. Bacri, and F. Gazeau: Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24, 1001 (2003).
17. C. Wilhelm, F. Gazeau, J. Roger, J. N. Pons, and J. C. Bacri: Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization. Langmuir 18, 8148 (2002).
18. C. Wilhelm and F. Gazeau: Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161 (2008).
19. J. Zhou, C. Leuschner, C. Kumar, J. Hormes, and W. O. Soboyejo: A TEM study of functionalized magnetic nanoparticles targeting breast cancer cells. Mater. Sci. Eng., C: Biomim. Supramol. Syst. 26, 1451 (2006).
20. A. S. Arbab, L. A. Bashaw, B. R. Miller, E. K. Jordan, B. K. Lewis, H. Kalish, and J. A. Frank: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229, 838 (2003).
21. J. A. Frank, B. R. Miller, A. S. Arbab, H. A. Zywicke, E. K. Jordan, B. K. Lewis, L. H. Bryant, and J. W. M. Bulte Jr: Clinically applicable labeling of mammalian cells and stem cells by combining superparamagnetic iron oxides and commonly available transfection agents. Radiology 228, 480 (2003).
22. C. Rivière, F. P. Boudghène, F. Gazeau, J. Roger, J. N. Pons, J. P. Laissy, E. Allaire, J. B. Michel, D. Letourneur, and J. F. Deux: Iron oxide nanoparticle-labeled rat smooth muscle cells: Cardiac MR imaging for cell graft monitoring and quantitation. Radiology 235, 959 (2005).
23. S. H. Ju, G. J. Teng, Y. Zhang, M. Ma, F. Chen, and Y. Y. Ni: In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood. Magn. Reson. Imaging 24, 611 (2006).
24. M. Song, W. K. Moon, Y. Kim, D. Lim, I. C. Song, and B. W. Yoon: Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: Comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J. Radiol. 8, 365 (2007).
25. S. Schwarz, F. Fernandes, L. Sanroman, M. Hodenius, C. Lang, U. Himmelreich, T. Schmitz-Rode, D. Schueler, M. Hoehn, M. Zenke, and T. Hieronymus: Synthetic and biogenic magnetite nanoparticles for tracking of stem cells and dendritic cells. J. Magn. Magn. Mater. 321, 1533 (2009).
26. E. Farrell, P. Wielopolski, P. Pavljasevic, N. Kops, H. Weinans, M. R. Bernsen, and G. J. van Osch: Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour. Osteoarthritis Cartilage 17, 961 (2009).
27. W. Slavin: Atomic absorption spectrometry. Methods Enzymol. 158, 117 (1988).
28. H. H. Hoepken, T. Korten, S. R. Robinson, and R. Dringen: Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J. Neurochem. 88, 1194 (2004).
29. A. N. Woodmansee and J. A. Imlay: Quantitation of intracellular free iron by electron paramagnetic resonance spectroscopy. Methods Enzymol. 349, 3 (2002).
30. V. Strom, K. Hultenby, C. Gruttner, J. Teller, B. Xu, and J. Holgersson: A novel and rapid method for quantification of magnetic nanoparticle-cell interactions using a desktop susceptometer. Nanotechnology 15, 457 (2004).
31. S. M. LeVine, M. J. Wulser, and S. G. Lynch: Iron quantification in cerebrospinal fluid. Anal. Biochem. 265, 74 (1998).
32. W. W. Fish: Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. Methods Enzymol. 158, 357 (1988).
33. P. E. Adams: Determining iron content in foods by spectrophotometry. J. Chem. Educ. 72, 649 (1995).
34. C. Gay, J. Collins, and J. M. Gebicki: Determination of iron in solutions with the ferric-xylenol orange complex. Anal. Biochem. 27, 143 (1999).
35. V. S. Kalambur, E. K. Longmire, and J. C. Bischof: Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 23, 12329 (2007).
36. A. Huberman and C. Perez: Nonheme iron determination. Anal. Biochem. 307, 375 (2002).
37. A. M. Rad, B. Janic, A. S. M. Iskander, H. Soltanian-Zadeh, and A. S. Arbab: Measurement of quantity of iron in magnetically labeled cells: Comparison among different UV/VIS spectrometric methods. Biotechniques 43, 627 (2007).
38. A. Jordan, R. Scholz, P. Wust, H. Schirra, T. Schiestel, H. Schmidt, and R. Felix: Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 194, 185 (1999).
39. V. H. B. Ho, A. Barcza, R. Chen, K. H. Müller, N. J. Darton, and N. K. H. Slater: The precise control of cell labelling with streptavidin paramagnetic particles. Biomaterials 30, 6548 (2009).
40. M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder: Noninvasive detection of clinically occult lymphnode metastases in prostate cancer. N. Engl. J. Med. 348, 2491 (2003).
41. B. R. Bacon, D. D. Stark, C. H. Park, S. Saini, E. V. Groman, P. F. Hahn, C. C. Compton, and J. T. Ferrucci: Ferrite particles: A new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. J. Lab. Clin. Med. 110, 164 (1987).
42. R. Weissleder, D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White, P. Jacobs, and J. Lewis: Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152, 167 (1989).